Health Care & Life Sciences » Biotechnology | MultiCell Technologies Inc.

MultiCell Technologies Inc.

MultiCell Technologies Inc.
Stock Exchange Other OTC
Market Cap
$1000 K
Shares Outstanding
5 B
Public Float
4.5 B


68 Cumberland Street
Woonsocket Rhode Island 02895
United States
Employees -
Updated 07/08/2019
MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer. Its therapeutic development platform includes several patented techniques used to isolate, characterize and differentiate stem cells from human liver or control the immune response at transcriptional and translational levels through dsRNA-sensing molecules, such as Toll-like receptor, RIG-I-like receptor, and MDA-5 signaling. The company was founded on April 28, 1970 and is headquartered in Woonsocket, RI.


View All

W. Gerald Newmin
Chairman, President, CEO, CFO & Secretary
Thomas A. Page
Independent Director